| Literature DB >> 28743913 |
Naghmeh Khoshgoo1,2,3, Robin Visser1,2, Landon Falk1,2, Chelsea A Day1,2, Dustin Ameis1,2, Barbara M Iwasiow1,2, Fuqin Zhu1,2, Arzu Öztürk4,5, Sujata Basu1,3, Molly Pind4,5, Agnes Fresnosa4,5, Mike Jackson6, Vinaya Kumar Siragam1,2, Gerald Stelmack1,3, Geoffrey G Hicks4,5, Andrew J Halayko1,3, Richard Keijzer7,8,9.
Abstract
miR-200b plays a role in epithelial-to-mesenchymal transition (EMT) in cancer. We recently reported abnormal expression of miR-200b in the context of human pulmonary hypoplasia in congenital diaphragmatic hernia (CDH). Smaller lung size, a lower number of airway generations, and a thicker mesenchyme characterize pulmonary hypoplasia in CDH. The aim of this study was to define the role of miR-200b during lung development. Here we show that miR-200b-/- mice have abnormal lung function due to dysfunctional surfactant, increased fibroblast-like cells and thicker mesenchyme in between the alveolar walls. We profiled the lung transcriptome in miR-200b-/- mice, and, using Gene Ontology analysis, we determined that the most affected biological processes include cell cycle, apoptosis and protein transport. Our results demonstrate that miR-200b regulates distal airway development through maintaining an epithelial cell phenotype. The lung abnormalities observed in miR-200b-/- mice recapitulate lung hypoplasia in CDH.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28743913 PMCID: PMC5526907 DOI: 10.1038/s41598-017-05412-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Generation and validation of miR-200b−/− mice (miR200btm1.1(NCOM)MFGC). (a) Targeted miR-200b knockout allele. The complete miR-200b non-coding gene (WT allele) was replaced by a NorCOMM cassette via targeted homologous recombination in C57Bl/6N mouse C2 ES cells. The NorCOMM targeting cassette consists of three functional components: a lacZ expression reporter (blue boxes); a loxP flanked (red triangles) hβact promoter driven ∆TK1-T2A-neomycin selectable marker (orange boxes), which can be subsequently excised by cre-recombinase; and a docking cassette AttP-Puro-pA that can be utilized to exchange the entire NorCOMM cassette to any other allele (purple boxes) and once placed, the remaining flanked sequences can be removed by flpO-recombinase between F3 and FRT sites (green triangles) in vivo. The length of 5′ and 3′ homology arms are 2891 bp and 6595 bp in the targeting vector, respectively. The targeted miR-200b gene was highlighted in the resulting knockout allele (KO Allele). (b) Targeted miR-200b knockout mice. Removal of the hβact promoter driven ∆TK1-T2A-neomycin cassette was performed by mating male miR200btm1(NCOM)MFGC mice harboring the miR-200b KO allele with female CMV-Cre transgenic mice. Precise cre-excision of the neomycin cassette was determined by PCR and sequence validation, as shown with primers specific to LacZ and Puro cassette by purple arrows in Panel C. The resultant miR-200b cre-excised allele is shown as miR200btm1(NCOM)MFGC. (c) LacZ staining of miR-200b−/− mice demonstrated the expression in both epithelial and mesenchymal cells during lung development. (d,e) Lung explants culture of E11.5 lung explants did not show significant differences in proximal branching morphogenesis between miR-200b+/+, miR-200b+/− and miR-200b−/− lungs. (f) RT-qPCR for all miR-200 family members on fetal lung explants using LNA primers. miR-200b absence was confirmed. miR-200a and miR-429 were significantly downregulated, but no changes were observed in abundance of miR-200c and miR-141 **P < 0.01, Student’s t-test, Data represent mean ± SEM of at least four independent experiments.
Figure 2miR-200b is required for normal lung function. (a) Lung mechanics studies performed on 8-week-old mice demonstrated that miR-200b−/− (ko) mice have higher lung tissue resistance (damping) when challenged with 6 mg/ml methacholine or higher (b) miR-200b ko mice have higher lung tissue stiffness (Elastance) at 12, 25 and 50 mg/ml of methacholine (c) and more conducting airway resistance at high concentrations of methacholine. (d) Accessing lung hysteresivity at the time of saline challenge (before methacholine challenge) showed lower hysteresivity in miR-200b ko mice. *P < 0.05, **P < 0.01, ***P < 0.001, two-way ANOVA. Data represent mean ± SEM of at least six independent experiments. (e) Biophysical surfactant function of miR-200b ko lungs (8-week-old) measured using capillary surfactometry. MiR-200b−/− mice have decreased surfactant function compared to wt. **P < 0.01, Student’s t-test, Data represent mean ± SEM of at least three independent experiments. (f,g) Immunofluorescence of 8-week-old wt (f) and ko (g) lungs showed decreased abundance of Surfactant Protein-B (SP-B) in ko lungs. (h,i) Immunofluorescence of 8-week-old wt (h) and ko (i) lungs showed decreased abundance of pro-Surfactant Protein-C (SP-C) in ko lungs.
Figure 3miR-200b knockout mice have denser parenchyma, thickened alveolar walls, lower distal branching and more fibroblast-like cells. (a) In vivo micro-CT scans of 8-weeks-old mice using the SkyScan 1176 x-ray microtomography system equipped with a large format 11 megapixel x-ray camera. MiR-200b knockout (ko) mice have denser lung parenchyma (gray area in the peripheral area) and a lower number of distal airways (smaller distance between the large airways). (b) miR-200b−/− lungs have significantly lower levels of lung air volume than miR-200b+/+. Lung airspace volume was measured on alive mice using micro-CT scan. *P < 0.05, Student’s t-test, Data represent mean ± SEM of at least three independent experiments. (c) Hematoxylin and eosin (H&E) staining of miR-200b−/− lungs confirmed that these lungs have less septation and thicker alveolar walls when compared to wild type lungs. (d) Area percentage of airspace of miR-200b−/− lungs was significantly decreased compare to miR-200b+/+ lungs. H&E stained peripheral lung sections were scanned and the percentage of airspace over total lung was measured using ZEN Image Analysis. (e,f) Immunostaining for Vimentin on wt (e) and ko (f) lungs demonstrated higher expression of Vimentin protein in ko parenchyma than the wt. (g,h) Immunofluorescence for Twist protein on wt (g) and ko (h) demonstrated higher expression of Twist in the ko than the wt. (i) Immunostaining of the miR-200b transfected cells after 48 h demonstrated higher expression of Vimentin and lower expression of Cytokeratin in these cells compared to cells transfected with a negative control. (j) A wound healing (scratch) assay was performed on BEAS-2B or control cells transfected with miR-200b inhibitors (for 18 h). Pictures were taken at time 0 h when the scratch was made and 18 h later and the migration rates were calculated (the difference between distance from the right to left border at 16 h divided by the distance from the right to left border at the start time).
Figure 4Next Generation Sequencing and Gene ontology (GO) showed the most affected pathways in the lungs of miR-200b−/− mice. (a) The heat map diagram shows the results of a two-way hierarchical clustering of RNA transcripts and samples. It includes the 500 genes that have the largest coefficient of variation based on FPKM counts. Each row represents one gene and each column represents one sample. The color represents the relative expression level of a transcript across all samples. The color scale is shown below: red represents an expression level above the mean; green represents an expression level below the mean. (wt samples: 867, 871 and 923; miR-200b ko samples: 875, 878 and 869). (b,c) Pie charts for transcript gene functional analysis conducted for Biological Pathway and Protein class using the PANTHER gene ontology database. (d) GO network generated from the GO terms predicted to be enriched for the Biological process (BP vocabulary). Nodes are colored from red to yellow with the node with the strongest support colored red and nodes with no significant enrichment colored yellow. The five nodes with strongest support are marked with rectangular nodes. (e,f,g) Q-PCR confirmed significantly lower Plunc, Cdh26 and Cyp2a5 mRNA levels in miR-200−/− (ko) lungs than miR-200+/+(wt).
The top 10 most significantly differentially expressed mRNAs, with log fold change (FPKM Log2_FC) between groups treatmentA (miR-200b+/+) and treatmentB (miR-200b−/−) with Benjamini-Hochberg FDR corrected q-values.
| Gene_id | Gene | Locus | treatmentA | treatmentB | Log2_fold_change | Q_value |
|---|---|---|---|---|---|---|
| XLOC_008125 | Lrrtm3 | 10:63430097–65003667 | 0.231458 | 0.00345736 | −6.06493 | 0.0355741 |
| XLOC_020864 | Tcrg-C2 | 13:19304679–19311304 | 50.7836 | 1.27343 | −5.31757 | 0.00634618 |
| XLOC_044124 | Bpifa1 or plunc | 2:154142879–154149219 | 1353.78 | 76.2106 | −4.15086 | 0.00634618 |
| XLOC_069330 | Slc5a11 | 7:123214779–123273253 | 0.0723419 | 1.11466 | 3.94563 | 0.00634618 |
| XLOC_008308 | Trpm2 | 10:77907721–77970563 | 17.5321 | 1.28117 | −3.77447 | 0.00634618 |
| XLOC_014662 | Krt15 | 11:100131757–100135928 | 6.93844 | 0.507409 | −3.77339 | 0.00634618 |
| XLOC_022181 | Thbs4 | 13:92751589–92794818 | 0.440093 | 0.033428 | −3.71868 | 0.0340586 |
| XLOC_014413 | Spata20 | 11:94478903–94486179 | 0.0590388 | 0.773681 | 3.712 | 0.00634618 |
| XLOC_067530 | Cyp2a5 | 7:26835304–26952462 | 282.331 | 23.1095 | −3.61083 | 0.00634618 |
| XLOC_044638 | Cdh26 | 2:178430530–178487366 | 4.61108 | 0.383838 | −3.58654 | 0.00634618 |
The significant GO terms for the genes found to be differentially expressed between treatmentA (wt) and treatmentB (ko) their corresponding annotation for Biological Function (BF).
| GO.ID | Term | Annotated | Significant | Expected |
|---|---|---|---|---|
| GO:0015031 | protein transport | 1142 | 7 | 11.13 |
| GO:0051301 | cell division | 435 | 6 | 4.24 |
| GO:0006886 | intracellular protein transport | 653 | 5 | 6.36 |
| GO:0046777 | protein autophosphorylation | 170 | 0 | 1.66 |
| GO:0006915 | apoptotic process | 1336 | 29 | 13.02 |
| GO:0007067 | mitosis | 306 | 3 | 2.98 |
| GO:0006397 | mRNA processing | 322 | 2 | 3.14 |
| GO:0008285 | negative regulation of cell proliferation | 451 | 5 | 4.39 |
| GO:0001701 | in utero embryonic development | 374 | 3 | 3.64 |
| GO:0043065 | positive regulation of apoptotic process | 295 | 10 | 2.87 |
| GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 534 | 5 | 5.2 |
| GO:0006281 | DNA repair | 357 | 0 | 3.48 |
| GO:0043066 | negative regulation of apoptotic process | 499 | 16 | 4.86 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 715 | 12 | 6.97 |
| GO:0009968 | negative regulation of signal transduction | 692 | 10 | 6.74 |
| GO:0045893 | positive regulation of transcription, DNA-dependent | 991 | 15 | 9.66 |
| GO:0007049 | cell cycle | 1135 | 10 | 11.06 |
| GO:0001666 | response to hypoxia | 225 | 11 | 2.19 |
| GO:0006355 | regulation of transcription, DNA-dependent | 2844 | 31 | 27.71 |
| GO:0006468 | protein phosphorylation | 1156 | 17 | 11.26 |
Annotated: Number of genes associated to the GO term, Significant: Number of significantly differentially expressed (p <= 0.05) genes within the annotated genes, Expected: Number of genes within the annotated genes that are expected to be significantly deferentially expressed (p < = 0.05) by random.